Want to see IN:BLUEJET full AI Analyst Report?
BLUEJET Stock Chart & Stats
₹653.45
-₹16.80(-2.80%)
At close: 4:00 PM EST
₹653.45
-₹16.80(-2.80%)
Day’s Range― - ―
52-Week Range₹325.20 - ₹688.00
Previous CloseN/A
Volume75.53K
Average Volume (3M)29.47K
Market Cap
₹98.04B
Enterprise Value₹53.45B
Total Cash (Recent Filing)₹3.23B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)38.2
Beta1.48
Next Earnings
Nov 05, 2026EPS Estimate
4.4Next Dividend Ex-DateN/A
Dividend Yield0.23%
Share Statistics
EPS (TTM)13.55
Shares Outstanding189,275,700
10 Day Avg. Volume13,949
30 Day Avg. Volume29,473
Financial Highlights & Ratios
PEG Ratio-1.22
Price to Book (P/B)4.17
Price to Sales (P/S)5.99
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.04
Revenue Forecast (FY)₹11.79B
Bulls Say, Bears Say
Bulls Say
Strong And Sustained ProfitabilityConsistently high gross and net margins indicate that Blue Jet has maintained meaningful economics across multiple years. This profitability can support reinvestment, absorb some cost pressure, and provide a stronger foundation for growth than a low-margin API business.
Exceptionally Conservative Balance SheetExtremely low leverage reduces financial risk and interest-related pressure, giving Blue Jet substantial flexibility through weaker operating periods. A conservative balance sheet also preserves capacity to fund working capital, investments, or expansion without relying heavily on additional borrowing.
Efficient Use Of Shareholder CapitalStrong reported returns on equity suggest the company has generated attractive earnings relative to its shareholder capital while continuing to build its equity base. This combination supports the view that the business has historically used capital efficiently, despite recent growth volatility.
Bears Say
Material FY2026 Revenue ContractionThe sharp FY2026 revenue decline interrupts the company’s earlier expansion and reduces visibility into demand and operating scale. If weaker sales persist, fixed-cost absorption, customer ordering patterns, and the ability to sustain historical profitability could all come under pressure.
Inconsistent Cash ConversionUneven conversion of reported earnings into cash weakens confidence in the quality and repeatability of profits. Weak operating cash flow relative to earnings and inconsistent free cash flow may constrain internally funded investment and signal recurring working-capital or timing pressures.
Recent Margin Compression And Weaker MomentumMargin compression after strong prior-year performance suggests that the recent revenue slowdown is affecting operating quality, not just the top line. A less favorable mix or weaker utilization could make it harder to preserve historical margins if subdued growth continues over coming quarters.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
Blue Jet Healthcare Limited lowest stock price was ₹325.20 and its highest was ₹688.00 in the past 12 months.
What is Blue Jet Healthcare Limited’s market cap?
Blue Jet Healthcare Limited’s market cap is ₹98.04B.
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
Blue Jet Healthcare Limited’s upcoming earnings report date is Nov 05, 2026 which is in 7 days.
How were Blue Jet Healthcare Limited’s earnings last quarter?
Blue Jet Healthcare Limited released its earnings results on Aug 03, 2026. The company reported ₹4.5 earnings per share for the quarter, beating the consensus estimate of ₹4.2 by ₹0.3.
Is Blue Jet Healthcare Limited overvalued?
According to Wall Street analysts Blue Jet Healthcare Limited’s price is currently Overvalued.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.23%. See more information on Blue Jet Healthcare Limited dividends here
What is Blue Jet Healthcare Limited’s EPS estimate?
Blue Jet Healthcare Limited’s EPS estimate is 4.4.
How many shares outstanding does Blue Jet Healthcare Limited have?
Blue Jet Healthcare Limited has 189,275,700 shares outstanding.
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Blue Jet Healthcare Limited reported an EPS of ₹4.5 in its last earnings report, beating expectations of ₹4.2. Following the earnings report the stock price went down -6.004%.
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
Currently, no hedge funds are holding shares in IN:BLUEJET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Ltd. is a company that focuses on the manufacturing and supply of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), which are critical components for the pharmaceutical and healthcare sectors. Its product offerings include integrated intermediates used in contrast media, saccharin and its associated salts, and a range of specialized pharmaceutical intermediates and APIs. The company also delivers comprehensive contract development and manufacturing (CDMO/CMO) and development services. Founded in 1968, Blue Jet Healthcare is headquartered in Thane, India, and maintains a broad international operational footprint across countries such as India, Norway, the United States, Sweden, Italy, and Spain.
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Syngene International Ltd.
―
OneSource Specialty Pharma Limited
―